Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
01 1Aarti Pharmalabs Limited
02 1Aurobindo Pharma Limited
03 1Glenmark Life Sciences Limited
04 1Hetero Drugs Limited
05 1MSN Pharmachem Private Limited
01 1Perindopril
02 3Perindopril Erbumine
03 1Perindopril tert-Butylamine
01 5India
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-1000
Start Marketing Date : 1994-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-804
Start Marketing Date : 2004-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-425
Start Marketing Date : 2023-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0019
Start Marketing Date : 1993-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0005
Start Marketing Date : 2010-04-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
75
PharmaCompass offers a list of Perindopril Erbumine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Perindopril Erbumine manufacturer or Perindopril Erbumine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Perindopril Erbumine manufacturer or Perindopril Erbumine supplier.
PharmaCompass also assists you with knowing the Perindopril Erbumine API Price utilized in the formulation of products. Perindopril Erbumine API Price is not always fixed or binding as the Perindopril Erbumine Price is obtained through a variety of data sources. The Perindopril Erbumine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AKOS015841351 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AKOS015841351, including repackagers and relabelers. The FDA regulates AKOS015841351 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AKOS015841351 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AKOS015841351 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AKOS015841351 supplier is an individual or a company that provides AKOS015841351 active pharmaceutical ingredient (API) or AKOS015841351 finished formulations upon request. The AKOS015841351 suppliers may include AKOS015841351 API manufacturers, exporters, distributors and traders.
click here to find a list of AKOS015841351 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AKOS015841351 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AKOS015841351 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AKOS015841351 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AKOS015841351 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AKOS015841351 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AKOS015841351 suppliers with NDC on PharmaCompass.
We have 5 companies offering AKOS015841351
Get in contact with the supplier of your choice:
